AMOEBA (EPA:ALMIB) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
AMOEBA

BRIEF

published on 10/07/2024 at 17:50, 1 month 13 days ago

Amoéba Publishes its Half-Yearly Financial Report as of June 30, 2024

AMOEBA Investors Financial Report Biocontrol Cosmetic
PRESS RELEASE

published on 10/07/2024 at 17:45, 1 month 13 days ago

Amoéba: Publication of the half-year financial report at 30 June 2024
Amoéba announces the publication of its half-year financial report for 2024 and upcoming institutional investor event. Amoéba, a greentech company, provides natural microbiological solutions

AMOEBA Investor Event Half-year Financial Report GreenTech Microbiological Solutions
BRIEF

published on 10/03/2024 at 17:50, 1 month 17 days ago

Amoéba confirms its strategic pivot in the first half of 2024

AMOEBA Strategy Biocontrol GreenTech Cosmetic
PRESS RELEASE

published on 10/03/2024 at 17:45, 1 month 17 days ago

Amoéba: the first half of 2024 confirms the strategic pivot towards an industrial and commercial company from 2025 onwards
Amoéba reports strategic shift to commercial focus & positive operating income growth in H1 2024. Financial outlook secured until mid-2025. Development plans for biocontrol & cosmetics segments

AMOEBA Financial Results Biocontrol Cosmetics Strategic Shift
BRIEF

published on 10/02/2024 at 17:50, 1 month 18 days ago

AMOEBA: Total number of voting rights and shares as of September 30, 2024

AMOEBA Voting Rights Capital Actions Financial Markets
BRIEF

published on 08/28/2024 at 17:50, 2 months 23 days ago

Amoéba Prepares for US Launch of AXPERA Product Line by 2025

Market Authorization 2025 Targets AXPERA Launch EPA Approval Biocontrol Products
PRESS RELEASE

published on 08/28/2024 at 17:45, 2 months 23 days ago

AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025
Amoéba's biofungicide products receive US EPA's admissibility confirmation for registration dossier, accelerating industrial and commercial development. Application for market authorization has been submitted. Collaboration with Dunham Trimmer in progress

AMOEBA Collaboration Market Authorization Biofungicide US EPA
BRIEF

published on 07/02/2024 at 08:35, 4 months 19 days ago

AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES

AMOEBA Biocontrol Cosmetics Legal Reorganisation Subsidiary
REGULATED PRESS RELEASE

published on 07/02/2024 at 08:30, 4 months 19 days ago

AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES
Amoéba announces a reorganisation to enhance commercial activities in biocontrol and cosmetics sectors, aiming to create value for shareholders. New legal structure to optimize resources and facilitate partnerships

AMOEBA Biocontrol Cosmetics Legal Structure Commercial Activities
BRIEF

published on 06/21/2024 at 13:41, 4 months 29 days ago

Edison Issues Report on Amoéba (ALMIB)

AMOEBA Financial Report Edison Investment Research ALMIB

1 2 ... 4

Accesswire

Published on 11/21/2024 at 10:03, 49 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 52 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 52 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 17 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 27 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 22 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 47 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 49 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 52 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 52 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 54 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 32 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 7 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 7 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE